Literature DB >> 17080581

Borrelia burgdorferi and Anaplasma phagocytophilum coinfection.

Micha Loebermann, Volker Fingerle, Matthias Lademann, Carlos Fritzsche, Emil C Reisinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080581      PMCID: PMC3373081          DOI: 10.3201/eid1202.050765

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: In central Europe, Anaplasma phagocytophilum and Borrelia burgdorferi are transmitted by the hard tick Ixodes ricinus (). Acute human granulocytic ehrlichiosis (HGE) caused by A. phagocytophilum has rarely been documented in Europe (). Typical symptoms include fever, headache, myalgia, leukopenia, thrombocytopenia, and abnormal liver function test results. The serologic prevalence ranges from 1.9% to 14% in Germany (), while clinically apparent infections of HGE have not been reported. Acute Lyme borreliosis in Europe is associated with erythema migrans (), recognized in up to 90% of patients (). Erythema migrans may be accompanied by systemic symptoms such as fever, fatigue, myalgia, arthralgia, headache, or stiff neck (,). In southern Germany, an incidence of 111 per 100,000 inhabitants has been reported (). A 60-year-old woman from northern Germany was admitted with temperature of <40°C, headache, myalgia, and generalized weakness that had begun 6 days earlier. She had noticed an erythema migrans on her right thigh 4 days before she sought treatment. At admission, a tender, 5 × 8 cm rash and a central papule were seen, but without central clearing. The clinical examination was otherwise normal. Three weeks earlier she had been on a trekking tour in Austria and Slovenia but had not been aware of any tick bites. The leukocyte count was 3,030/μL (normal 4,000–9,000), with 65% neutrophils, 24% lymphocytes, 10% monocytes, and 1% lymphoid cells. The following results were observed: platelets 127,000/μL (normal 150,000–450,000), aspartate aminotransferase 108 U/L (normal <31), alanine aminotransferase 154 U/L (normal <34), gamma-glutamyl transferase 98 U/L (normal <38), lactate dehydrogenase 317 U/L (normal <247), alkaline phosphatase 314 U/L (normal <237), direct bilirubin 4.7 μmol/L (normal <3.4), C-reactive protein 132 mg/L (normal <5), and neopterin 30 nmol/L (normal <10). All other routine laboratory parameters were normal. May-Grünwald-Giemsa (Fluke, Neu Ulm, Germany)–stained whole-blood smears did not show Anaplasma initially and during follow-up. On admission serum antibody tests were negative for A. phagocytophilum, B. burgdorferi, hepatitis A, B, and C, human herpes virus 6, herpes simplex virus 1 and 2, Epstein-Barr virus, cytomegalovirus, and tickborne encephalitis virus. Because Lyme borreliosis and possible HGE were suspected, the patient was treated with oral doxycycline 200 mg once daily for 3 weeks. Within 4 days after initiation of treatment, the patient recovered completely; thrombocytes and leukocytes had normalized. Liver enzyme levels were still elevated but had normalized at a follow-up examination 28 days later. Four days after the initial examination, results for Borrelia-specific immunoglobulin M (IgM) antibodies were positive, while results for IgG antibodies remained negative (Table). Four weeks after the onset of symptoms, a test for A. phagocytophilum–specific IgM antibodies was positive and IgG was negative thereafter (Table). An initial EDTA blood sample that was stored frozen and examined retrospectively as well as follow-up EDTA blood samples were negative for A. phagocytophilum in a polymerase chain reaction (PCR) assay.
Table

Results of serologic tests at diagnosis and during follow-up*

Time (d) after onset of symptomsAnaplasma (Ehrlichia) phagocytophilum (IFA)†
Borrelia burgdorferi (ELISA)‡
Borrelia burgdorferi (Immunoblot)§
IgMIgGIgMIgGIgMIgG
6Negative (<1:20)Negative (<1:32)NegativeNegativeNegativeNegative
10NDNDPositiveNegativeNDND
28Positive (1:40)Negative (1:32)PositiveNegativePositiveNegative
107Positive (1:20)Negative (<1:32)PositiveNegativePositiveNegative
380Negative (<1:20)Negative (<1:32)EquivocalNegativePositiveNegative

*Symptoms (fever, headache, myalgia) started 6 days before presentation. IFA, immunofluorescent assay; ELISA, enzyme-linked immunosorbent assay; Ig, immunoglobulin; ND, not done.
†Genzyme Virotech, Germany. Positive titers: IgM >1:20, IgG >1:64.
‡Behring, Germany.
§In-house Immunoblot, Max von Pettenkofer-Institut, Munich, Germany.

*Symptoms (fever, headache, myalgia) started 6 days before presentation. IFA, immunofluorescent assay; ELISA, enzyme-linked immunosorbent assay; Ig, immunoglobulin; ND, not done.
†Genzyme Virotech, Germany. Positive titers: IgM >1:20, IgG >1:64.
‡Behring, Germany.
§In-house Immunoblot, Max von Pettenkofer-Institut, Munich, Germany. One year after initial examination, results for Borrelia-specific IgM antibodies were positive and results for A. phagocytophilum-specific antibodies were negative (Table). Although HGE has not been reported in Germany, a coinfection with B. burgdorferi and A. phagocytophilum should be considered in patients with erythema migrans and atypical changes for Lyme borreliosis such as fever, leukopenia, thrombocytopenia, and elevated liver function test results. The patient had traveled to an area where both tickborne pathogens, A. phagocytophilum and B. burgdorferi, were endemic. Erythema migrans and antibody follow up suggested Lyme borreliosis. High fever, leukopenia, thrombocytopenia, and elevated liver enzyme levels indicated HGE. Anaplasma PCR was negative, possibly because blood samples were tested retrospectively after 3 months of storage at –20°C. However, a commercially available indirect fluorescent antibody assay was able to demonstrate seroconversion of HGE-specific IgM antibodies 1 month after the initial onset of symptoms. According to manufacturer's information, specificity ranged from 97.5% to 100%; sensitivity was 71.4% at 60 days after A. phagocytophilum infection. A. phagocytophilum IgG antibodies were not detected during follow-up, likely because of prompt treatment with doxycycline. Wormser et al. () suggested that Borrelia-specific antibodies might indicate false-positive results in patients with HGE infection. Our case, however, meets criteria of a newly acquired infection with B. burgdorferi sensu lato, with an erythema migrans and seroconversion of Borrelia-specific IgM antibodies.
  4 in total

1.  Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia.

Authors:  S Lotric-Furlan; M Petrovec; T Avsic-Zupanc; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Infect Dis       Date:  2001-07-09       Impact factor: 9.079

2.  Incidence of Lyme borreliosis in the Würzburg region of Germany.

Authors:  H I Huppertz; M Böhme; S M Standaert; H Karch; S A Plotkin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

3.  False-positive Lyme disease serology in human granulocytic ehrlichiosis.

Authors:  G P Wormser; H W Horowitz; J S Dumler; I Schwartz; M Aguero-Rosenfeld
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

4.  Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups.

Authors:  V Fingerle; J L Goodman; R C Johnson; T J Kurtti; U G Munderloh; B Wilske
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

  4 in total
  9 in total

1.  Broad-range survey of tick-borne pathogens in Southern Germany reveals a high prevalence of Babesia microti and a diversity of other tick-borne pathogens.

Authors:  Mark W Eshoo; Chris D Crowder; Heather E Carolan; Megan A Rounds; David J Ecker; Heike Haag; Benedikt Mothes; Oliver Nolte
Journal:  Vector Borne Zoonotic Dis       Date:  2014-08       Impact factor: 2.133

Review 2.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans.

Authors:  D Hulínská; J Votýpka; D Vanousová; J Hercogová; V Hulínský; H Drevová; Z Kurzová; L Uherková
Journal:  Folia Microbiol (Praha)       Date:  2009-08-02       Impact factor: 2.099

4.  Epidemiological survey of tick-borne encephalitis virus and Anaplasma phagocytophilum co-infections in patients from regions of the Czech Republic endemic for tick-borne diseases.

Authors:  Petr Zeman; Petr Pazdiora; Vaclav Chmelik; Jiri Januska; Karel Sedivy; Alberto A Guglielmone; Jorge A Iriarte; Zuzana Medkova
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 5.  Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.

Authors:  Igor Dumic; Dorde Jevtic; Mladjen Veselinovic; Charles W Nordstrom; Milan Jovanovic; Vanajakshi Mogulla; Elmira Mofid Veselinovic; Ann Hudson; Gordana Simeunovic; Emilia Petcu; Poornima Ramanan
Journal:  Microorganisms       Date:  2022-07-15

6.  Clinical features of 705 Borrelia burgdorferi seropositive patients in an endemic area of northern Italy.

Authors:  Giuseppe Stinco; Maurizio Ruscio; Serena Bergamo; Davide Trotter; Pasquale Patrone
Journal:  ScientificWorldJournal       Date:  2014-01-16

7.  Are patients with erythema migrans who have leukopenia and/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus?

Authors:  Franc Strle; Petra Bogovič; Jože Cimperman; Vera Maraspin; Katarina Ogrinc; Tereza Rojko; Daša Stupica; Lara Lusa; Tatjana Avšič-Županc; Katja Strašek Smrdel; Mateja Jelovšek; Stanka Lotrič-Furlan
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

8.  Assessing the Need for Multiplex and Multifunctional Tick-Borne Disease Test in Routine Clinical Laboratory Samples from Lyme Disease and Febrile Patients with a History of a Tick Bite.

Authors:  Kunal Garg; T Sakari Jokiranta; Sanna Filén; Leona Gilbert
Journal:  Trop Med Infect Dis       Date:  2021-03-17

9.  Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases.

Authors:  Kunal Garg; Leena Meriläinen; Ole Franz; Heidi Pirttinen; Marco Quevedo-Diaz; Stephen Croucher; Leona Gilbert
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.